메뉴 건너뛰기




Volumn 36, Issue 7-8, 2001, Pages 577-595

Prodrug strategies in cancer therapy

Author keywords

ADEPT; Armed antibodies; GDEPT; Hypoxia; Peptide conjugates; Tumour activated prodrugs

Indexed keywords

1 (2 BROMOETHYLAMINO) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 1 AZIRIDINO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 1,4 BIS[[2 (DIMETHYLAMINO N OXIDE)ETHYL]AMINO] 5,8 DIHYDROXYANTHRAQUINONE; 5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; 5 (1 AZIRIDINYL) 3 HYDROXYMETHYL 2 (3 HYDROXY 1 PROPENYL) 1 METHYL 4,7 INDOLEDIONE; AMIDASE; AMIDE; ANTINEOPLASTIC AGENT; AROMATIC NITRO COMPOUND; DOXORUBICIN; DU 257; ETANIDAZOLE; FLUOROURACIL; GEMTUZUMAB OZOGAMICIN; GLYCOSIDASE; GYRASE INHIBITOR; IMIDAZO[1,2 A]QUINOXALINE N OXIDE DERIVATIVE; KM 231; L 377202; METAL COMPLEX; MONOCLONAL ANTIBODY; NITROIMIDAZOLE; OXIDE; PEPTIDASE; PHOSPHATASE; PHOSPHOTRANSFERASE; PORFIROMYCIN; PRODRUG; QUINOLINECARBONITRILE; QUINONE DERIVATIVE; RACHELMYCIN; RB 90740; SB 408075; SN 23862; TIRAPAZAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZD 2767;

EID: 0035415493     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(01)01253-3     Document Type: Article
Times cited : (275)

References (183)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.